healthcare communications

Nancy Hicks's picture

Interview with the Authors: Nancy Hicks and Christina Nicols


Nancy Hicks, SVP and associate director, North America
Healthcare Practice,[[wysiwyg_imageupload:105:height=221,width=151]] and
Christina Nicols, VP and director of Research, Ketchum Washington, D.C., co-authors and editors of a new book entitled Health Industry Communications: New Media, New Methods, New Message sat down with Ketchum Corporate Communications Editor Jeff Lewonczyk to shed some light on the book, what communicators can learn from it, and overall trends in health industry communications.


JEFF: What is the goal of the book? What need does it fulfill, and what audiences is it intended for? Read full post »

Suzannah Palinkas's picture

What the Pirate Code Can Teach Us about Social Media in Pharma


Recently, Suzannah Palinkas, Vice President, [[wysiwyg_imageupload:102:]]

Healthcare, Washington , D.C., attended the ExL Pharma 5th Annual Digital Pharma East conference in Philadelphia, PA. The following is the first installment in a series of posts inspired by insights gathered at the conference. 

“The pirate code is more what you'd call ‘guidelines’ than actual rules.”

– Captain Barbossa, Pirates of the Caribbean

  Read full post »

Douglas Petkus's picture

Litigation Floodwaters: Can Congress Actually Help?


Douglas Petkus is an award-winning communications professional with a diverse range of experience in editorial, agency and corporate environments.  He is currently the president of Petkus Communications Consultants, LLC, a public relations consultancy specializing in senior-level communications counsel.  A guest contributor to Health-E Minds, the following post reflects Doug’s perspective on the current state of litigation in the world of pharma, based on his many years of professional experience in this arena. – Nancy Hicks, Senior Vice President, Associate Director, Ketchum North America Healthcare Practice

  Read full post »

Deirdre Middleton's picture

Seeing Pink? Be Cautious About Clashing Colors with Products


With October now behind us, we say goodbye to
the ribbons and tributes that p[[wysiwyg_imageupload:100:]]aint the town pink and make us all focus on breast cancer, its impact on everyone and the importance of doing what we can do to promote research and identify ways to help people survive.  We have seen the pink and blue and red cause programs for several years now and people are beginning to wonder:  “Does this brand really mean it or are they simply trying to make a sale?” 

Since trends and growing concerns are often given names, the public has turned this question into the accusing term “pinkwashing,” or “redwashing,” or “just the color-of-the-cause” washing.  They all mean the same thing – consumers think that brands are using causes to create affinity and to encourage purchase. Read full post »

Maria Patey's picture

Advertising + Prescription-only Drugs = Legal Minefield


Advertising prescription-only drugs in the EU is a
legal m[[wysiwyg_imageupload:99:]]inefield for drug makers, but for the moment, even in the age of ‘information anywhere’ the strict rules will remain.

This month, the European Commission has been in the headlines with an update relevant for all drug makers, communicators, advertisers and generally anybody responsible for the branding, promotion or distribution of prescription-only drugs across Europe. The update was announced after what appears to have been a review, prompted by proposals that there is increasing interest by patients to have a better understanding of the medicines they take. Read full post »